Intelligent bio solutions partners with spirit group as australian distributor, expanding community impact with intelligent fingerprinting drug testing solution

New york, oct. 09, 2024 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (“inbs” or the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its distribution partnership with spirit group, an australian, indigenous-owned marketing and consulting agency, with prominent clients across a wide range of industries, including mining, transportation and construction. spirit group will bring inbs' intelligent fingerprinting drug testing solution to government and corporate clients across australia.
INBS Ratings Summary
INBS Quant Ranking